Pfizer hopes to market an OTC Lipitor version after FDA approval
Earlier on Wednesday, Pfizer Inc. refrained from commenting on reports and looks forward to commence marketing of an over-the-counter (OTC)
Read more
Clinical Research Society
International Society for Clinical Research and Translational Medicine